YOU SEARCHED BY...
SEARCH BY...
States
- California(4)
- Connecticut(1)
- Florida(1)
- Illinois(2)
- Indiana(1)
- Maryland(1)
- Massachusetts(3)
- Michigan(2)
- Minnesota(2)
- New Hampshire(1)
- New Jersey(6)
- New York(3)
- Ohio(1)
- Oklahoma(2)
- Pennsylvania(8)
- Tennessee(1)
- Utah(1)
Contract Service Directory
Boston Analytical, Inc.
Company Headquarters
14 Manor Parkway
Salem, NH 03079
United States
Contract Service Directory
- Analytical Laboratory Services
- Analytical Methods Development
- Analytical Validation Studies
- Chemical Analysis
- Dissolution Testing
- Environmental Monitoring
- Extractables / Leachables Testing
- Methods Development
- Methods Validation
- Microbiological Testing
- Photostability
- Raw Materials Analysis
- Stability, ICH
- Sterility Testing
Related Content
-
Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease
Initiative, together with the Broad Institute of MIT and Harvard, aims to accelerate efforts to mine genetic data for insights into disease mechanisms.09.15.21
-
Promotions & Moves
Avacta Names Fiona McLaughlin as Therapeutics Division CSO
Dr. McLaughlin is a highly experienced oncology drug developer, bringing over 25 years of experience in research and translational drug development.09.02.21
-
Breaking News | Facilities | Industry News
Sai Life Sciences Opens New Biology Facility in Hyperbad, India
Positions itself as a differentiated player in Discovery Biology.08.19.21
-
Breaking News | Drug Development | Drug Discovery | Industry News | Laboratory Testing
Astellas, LabCentral Partner to Help Emerging Biotechs Accelerate Research
Future Innovator Prize offers one-year use of LabCentral's state-of-the-art lab facility in Cambridge, MA and access to Astellas' R&D capabilities.08.18.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Lykan and Vineti Form Cell Therapy Agreement
Partnership will streamline process development and manufacturing to deliver therapies to patients in need.08.13.21
-
Promotions & Moves
Valneva Appoints Ops SVP
Vincent Dequenne has an extensive track record in the pharmaceutical industry with more than 20 years of manufacturing and production experience.07.07.21
-
Breaking News | Industry News | Laboratory Testing
-
CDMO Market Trends & Opportunities
CDMOs have been some of the biggest winners from COVID contracts and will see benefits for several more years to come. A Q&A with GlobalData’s Peter Shapiro.Tim Wright, Editor, Contract Pharma 05.05.21
-
Breaking News | Collaborations & Alliances | Industry News
Elektrofi, Argenx Enter Collaboration and License Agreement
Will explore new subcutaneous formulations for therapeutic products directed at the human neonatal Fc receptor.Charles Sternberg, Assistant Editor 04.27.21
-
Breaking News | Drug Development | Industry News
Bristol Myers Squibb Expands at Cambridge Crossing
Adds remaining 113,000 square feet to its initial lease at 250 Water Street.Kristin Brooks 04.16.21
-
Breaking News | Industry News | Promotions & Moves
Recro Pharma Expands Business Development Team
Adds six new members, including sales representatives and regional representatives.Charles Sternberg, Assistant Editor 04.05.21
-
Breaking News | Industry News | Promotions & Moves
Rentschler Biopharma Names Martin Kessler as New CEO in U.S.
Will drive company-wide transformation and lead the ongoing expansion at the U.S. site.Tim Wright, Editor, Contract Pharma 03.31.21
-
Breaking News | Formulation Development | Industry News
Rentschler, Leukocare Extend Service Offering with U.S. Site
Opens Leukocare’s U.S. development labs and offices at Rentschler's facility in the Greater Boston area, where the two companies will work together.Kristin Brooks 03.22.21
-
Promotions & Moves
Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer
He succeeds Walter J. Kaczmarek III, who is stepping down as Chief Executive Officer.
-
Breaking News | Collaborations & Alliances | Drug Development
Selexis SA and BITT Enter Service Agreement
Will develop the cell line for BITR2101, BITT’s lead tumor necrosis factor receptor 2 oncology candidate.Charles Sternberg, Assistant Editor 03.10.21
-
Promotions & Moves
Jubilant Therapeutics Appoints Chief Scientific Officer
Luca Rastelli brings more than 20 years of oncology drug discovery and development experience.Kristin Brooks 03.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
BMS Expands Cell Therapy Manufacturing Capabilities
New state-of-the-art cell therapy manufacturing facility under construction to expand global footprint.Tim Wright, Editor, Contract Pharma 03.01.21
-
Breaking News | Industry News
KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
New lineup aims to address challenges from early stage powder characterization and formulation development to scale-up and production.Contract Pharma Staff 01.15.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
FUJIFILM Diosynth Biotechnologies will provide GMP contract process development and manufacturing services as part of its role in the new center.Contract Pharma Staff 01.14.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Delivery | Facilities | Industry News | Solid Dosage/Semi-solids
Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.Contract Pharma Staff 01.13.21
-
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Information Technology
Leukocare Starts Operations in the US
Opens development laboratories and offices in Boston area.Contract Pharma Staff 01.11.21
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Fujifilm to Invest $40M in New Facility
State-of-the-art viral vector and advanced therapy process development and manufacturing facility will be located in Boston area.Contract Pharma Staff 01.05.21
-
Breaking News | Industry News
AstraZeneca to Acquire Alexion in $39B Deal
Expands scientific presence in immunology by adding Alexion's innovative complement-technology platforms and strong pipeline, and top seller Soliris.Contract Pharma Staff 12.14.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Vibalogics Establishes U.S. Presence
Will open virotherapy facility in Boston and plans to invest $150 million.Contract Pharma Staff 11.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Promotions & Moves
Novavax Makes Leadership Changes
Appoints Gregory F. Covino as executive vice president and chief financial officer.Contract Pharma Staff 11.11.20
-
Bio News | Breaking News | Drug Development | Facilities | Industry News
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
Sai Life Sciences to Expand Biology Capabilities
Begins construction of new 75,000 sq. ft. facility in Hyderabad; adding 170 biologists to team.Contract Pharma Staff 10.28.20
-
Breaking News | Industry News | Promotions & Moves
Vigene Biosciences Appoints COO
Molly McGlaughlin brings 27 years of experience in biologics manufacturing and development.Contract Pharma Staff 10.15.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
iBio Enters into Agreement with Safi Biosolutions
To develop growth factors and cytokines using the FastPharming system.Contract Pharma Staff 10.06.20
-
Drug Development
New York City is Not Dead, Our Life Sciences Sector is Thriving
Amid the COVID-19 pandemic, life sciences is booming in NYC!Sara Jane Demy, CEO & Founder, Demy-Colton 10.01.20
-
Promotions & Moves
CROS NT Appoints President of North American Ops
Paul has more than 25 years of experience serving customers and managing clinical trials05.30.17
-
APIs | cGMP Manufacture | Industry News
Cambrex Expands Capacity and Capabilites in Sweden
Installs new multi-purpose reactors, adds continuous flow technology at Karlskoga Facility05.30.17
-
cGMP Manufacture | Clinical Trial Materials | Formulation Development | Industry News
Quotient Clinical Appoints Chief Commercial Officer
Kalim to support further expansion of global commercial footprint05.30.17
-
Breaking News | Promotions & Moves
-
Breaking News | Drug Development | Drug Discovery | Facilities | Industry News
-
-
Breaking News | Facilities | Industry News | Regulatory Affairs | Serialization
PCI Pharma Services Triples Serialization Capacity
Partners with Antares Vision, Marchesini and Domino for latest installation03.06.17
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Facilities | Industry News
MilliporeSigma Expands Biodevelopment Centers
New facilities in NA and China along with full single-use GMP facility in France to accelerate development of biologics01.10.17
-
Drug Development | R&D
Drug Development in Today’s Changing Healthcare Market
John Corcoran of Trinity Partners discusses what’s next for the life sciences industryKristin Brooks, Contract Pharma 01.04.17
-
Cold Chain Management | Industry News | Logistics
-
Bioassay Development | Breaking News | Chemistry | Drug Development | Industry News | Methods Development | Process Development | R&D | Toxicology
-
APIs | Bioassay Development | Breaking News | Capsules | Drug Development | Drug Discovery | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Methods Development | Process Development | Toxicology
-
Bioassay Development | Breaking News | Drug Development | GMPs/GCPs | Industry News | Inspections | Methods Development | Process Development | Regulatory Affairs | Toxicology
Camargo Marks 10-Year Anniversaries
Celebrates company’s founding and 505(b)(2) approval pathway06.05.13
-
Breaking News | Industry News
CLC bio Expands Operations
CLC bio is expanding in both North and South America with the opening of a new location in Boston, MA and a new Government Sector Branch in the Washington, D.C. area.09.03.10
